|
Volumn 122, Issue 10, 2012, Pages 2210-2215
|
Management of nonesthesioneuroblastoma sinonasal malignancies with neuroendocrine differentiation
|
Author keywords
head and neck; Neuroendocrine tumors; outcomes; radiotherapy; sinonasal
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ADJUVANT CHEMORADIOTHERAPY;
ADULT;
CANCER CHEMOTHERAPY;
CANCER CONTROL;
CANCER SURVIVAL;
CELL DIFFERENTIATION;
CLINICAL ARTICLE;
FEMALE;
FOLLOW UP;
HUMAN;
HUMAN TISSUE;
MALE;
MEDICAL RECORD REVIEW;
METASTASIS;
NEUROBLASTOMA;
NEUROENDOCRINE DISEASE;
NONESTHESIONEUROBLASTOMA;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
REVIEW;
SINONASAL CANCER;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA;
CELL DIFFERENTIATION;
CEREBROSPINAL FLUID RHINORRHEA;
CHEMORADIOTHERAPY, ADJUVANT;
DISEASE-FREE SURVIVAL;
ENDOSCOPY;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
KAPLAN-MEIER ESTIMATE;
MALE;
MAXILLARY SINUS NEOPLASMS;
NEOADJUVANT THERAPY;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
OSTEORADIONECROSIS;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 84866909590
PISSN: 0023852X
EISSN: 15314995
Source Type: Journal
DOI: 10.1002/lary.23463 Document Type: Review |
Times cited : (15)
|
References (10)
|